We are live on ! Find out more
CDTX

Cidara Therapeutics

Delisted

CDTX was delisted on the 6th of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
BB
1
BB Biotech
Switzerland
$11.9M
BI
2
BVF Inc
California
$10M +$9.11M +96,534 New
OFM
3
Omega Fund Management
Massachusetts
$7.85M +$5.02M +53,192 +239%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$7.65M
IVM
5
InterWest Venture Management
California
$7.05M
FM
6
Frazier Management
Washington
$6.82M
OM
7
Opaleye Management
Massachusetts
$6.24M +$5.66M +60,000 New
PM
8
Prosight Management
Texas
$6.03M -$131K -1,383 -2%
AC
9
Aisling Capital
New York
$5.31M
Millennium Management
10
Millennium Management
New York
$3.76M +$629K +6,658 +23%
Vanguard Group
11
Vanguard Group
Pennsylvania
$2.99M +$44.4K +470 +2%
MIM
12
Monashee Investment Management
Massachusetts
$2.5M
GIM
13
Granahan Investment Management
Massachusetts
$2.37M +$2.15M +22,800 New
SCM
14
Stonepine Capital Management
Oregon
$2.21M +$2.01M +21,277 New
BlackRock
15
BlackRock
New York
$1.59M +$270K +2,857 +23%
RSCM
16
Rock Springs Capital Management
Maryland
$1.56M
Renaissance Technologies
17
Renaissance Technologies
New York
$1.48M +$111K +1,180 +9%
Invesco
18
Invesco
Georgia
$1.13M +$1.03M +10,893 New
DCM
19
DAFNA Capital Management
California
$1.11M +$895K +9,481 +819%
RJA
20
Raymond James & Associates
Florida
$1.02M +$472K +4,996 +104%
RJFSA
21
Raymond James Financial Services Advisors
Florida
$877K +$470K +4,981 +144%
TCM
22
Tekla Capital Management
Massachusetts
$826K
WFI
23
West Family Investments
California
$800K +$254K +2,694 +54%
ACM
24
Alethea Capital Management
Washington
$567K +$147K +1,560 +40%
Goldman Sachs
25
Goldman Sachs
New York
$524K -$6.33K -67 -1%